(Q38465422)

3 September 2017

title

Effect of rosuvastatin on hemoglobin levels in patients with anemia and low-grade inflammation: a post hoc analysis of the JUPITER trial (English)

1 reference

3 September 2017

4

Paul M Ridker

1 reference

3 September 2017

3

Robert J Glynn

1 reference

3 September 2017

2

Daniel H Solomon

1 reference

3 September 2017

1

M Alan Brookhart

1 reference

3 September 2017

language of work or name

1 reference

28 December 2010

1 reference

The Journal of Clinical Pharmacology

3 September 2017

published in

1 reference

3 September 2017

volume

51

1 reference

3 September 2017

issue

10

1 reference

3 September 2017

page(s)

1483-1487

1 reference

Prevalence of anemia in persons 65 years and older in the United States: evidence for a high rate of unexplained anemia

3 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F0091270010386607

Anemia of chronic disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270010386607

The gene encoding the iron regulatory peptide hepcidin is regulated by anemia, hypoxia, and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270010386607

Regulatory defects in liver and intestine implicate abnormal hepcidin and Cybrd1 expression in mouse hemochromatosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270010386607

Regulation of iron homeostasis in anemia of chronic disease and iron deficiency anemia: diagnostic and therapeutic implications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270010386607

Hepcidin and its role in regulating systemic iron metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270010386607

Interleukin-6 induces hepcidin expression through STAT3

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270010386607

Age-associated increased interleukin-6 gene expression, late-life diseases, and frailty

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270010386607

Inflammatory cytokines stimulated C-reactive protein production by human coronary artery smooth muscle cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270010386607

IL-6 receptor inhibition with tocilizumab improves treatment outcomes in patients with rheumatoid arthritis refractory to anti-tumour necrosis factor biologicals: results from a 24-week multicentre randomised placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270010386607

Effect of statin therapy on C-reactive protein levels: the pravastatin inflammation/CRP evaluation (PRINCE): a randomized trial and cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270010386607

Statins reduce interleukin-6-induced C-reactive protein in human hepatocytes: new evidence for direct antiinflammatory effects of statins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270010386607

Effect of fluvastatin on serum prohepcidin levels in patients with end-stage renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270010386607

Rosuvastatin in the primary prevention of cardiovascular disease among patients with low levels of low-density lipoprotein cholesterol and elevated high-sensitivity C-reactive protein: rationale and design of the JUPITER trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270010386607

Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270010386607

Reduction in C-reactive protein and LDL cholesterol and cardiovascular event rates after initiation of rosuvastatin: a prospective study of the JUPITER trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270010386607

A randomized trial of rosuvastatin in the prevention of venous thromboembolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270010386607

21 January 2018

Identifiers

DOI

10.1177/0091270010386607

1 reference

3 September 2017

1 reference